Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting".
Lilian van WagensveldOlivier ColombanMaaike A van der AaGilles FreyerGabe S SonkeRoy F P M KruitwagenBenoit YouPublished in: Journal of gynecologic oncology (2024)
The value of KELIM, as a pragmatic indicator of response to chemotherapy, was maintained in a large real-life population-based cohort, highlighting its applicability in routine conditions.